Related Experiment Videos
[Current therapy of lung carcinoma]
1Department of Thoracic and Cardiovascular Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Journal of UOEH
|June 1, 1993
Summary
Lung carcinoma survival rates remain low despite increased incidence. This study analyzes surgical and chemotherapy roles for advanced lung cancer patients, discussing adjuvant combination therapy effectiveness.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Context:
- Lung carcinoma incidence is high, yet survival rates have not significantly improved.
- Surgical resection is the primary treatment for lung carcinoma.
- Adjuvant combination therapy with neoplastic agents is increasingly used.
Purpose:
- To analyze clinical data of resected lung carcinoma patients.
- To discuss the roles of surgery and chemotherapy in managing advanced lung carcinoma stages.
Summary:
- Clinical data from resected lung carcinoma patients were analyzed.
- The study evaluated the effectiveness of surgical resection combined with adjuvant chemotherapy for advanced lung cancer.
- The findings discuss the integrated role of surgical intervention and chemotherapeutic agents.
Impact:
- Provides insights into optimizing treatment strategies for advanced lung carcinoma.
- Highlights the importance of multimodal approaches including surgery and chemotherapy.
- Contributes to the understanding of lung cancer management and patient outcomes.